InflaRx NV Doses First Volunteer in Phase 1 Trial of INF904 | MarketScreener

The placebo-controlled study has been designed to evaluate y safety, tolerability, and pharmacokinetics of INF904 in healthy volunteers, the company … Read source

Click to rate this post!
[Total: 0 Average: 0]
Scroll to Top